Group structure

Through Hutchison MediPharma, Chi-Med researches and develops TCM-derived botanical, semi-synthetic natural product drugs, and synthetic single chemical entity drugs for the global and the Chinese pharmaceutical market. Chi-Med focus on the oncology and auto-immune therapeutic areas.

Chi-Med has operation joint ventures in the major, fast growing and still highly fragmented China TCM market: Hutchison Baiyunshan; Shanghai Hutchison Pharmaceuticals; and Hutchison Healthcare. They develop, manufacture and market TCM pharmacenticals and health supplements both prescription and over-the-counter Chi-Med plans to estabish further joint ventures in the near future.

Chi-Med is developing "Sen" as a quality TCM consumer brand in TCM medicines and treatments, food & beverage, and skin and body care products through its own network of retail stores with the aim also of developing licensing deals with large-scale consumer products companies.